Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

298
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
298
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

309
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
309
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

628
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
628
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

319
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
319
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

274
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
274
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

264
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
264

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Methodological and inferential limits before abandoning follow-up in node-negative typical lung carcinoids.

Journal of neuroendocrinology·2026
Same author

The NET score: an interpretable AI-assisted prognostic score for mortality risk in lung neuroendocrine tumors.

Endocrine-related cancer·2026
Same author

Safety and Efficacy of Single-Stage Synchronous Bilateral VATS Talc Poudrage for Malignant Pleural Effusion.

Cancers·2026
Same author

Concordance of Actionable Driver Alterations Between Primary Lung Adenocarcinoma and Paired Thoracic Metastases: A Prospective Next-Generation Sequencing Study.

Cancers·2026
Same author

Correction: Prisciandaro et al. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis. <i>Cancers</i> 2026, <i>18</i>, 1037.

Cancers·2026
Same author

Multidisciplinary Decision-Making and Integrated Strategies in Stage III Non-Small Cell Lung Cancer: Exploring Clinical Reasoning in Therapeutic Choices.

Journal of clinical medicine·2026

相关实验视频

Updated: Jan 13, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.4K

复发性恶性心周溢血的管理:心周周周周的窗口.

Antonio Mazzella1, Giovanni Caffarena1, Claudia Bardoni1

  • 1Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.

Journal of clinical medicine
|January 10, 2026
PubMed
概括

心周周围膜窗口 (PPW) 是一种安全有效的手术选择,用于在预后良好的患者中管理恶性心周周周围膜溢出 (MPE). 对于那些前景不太好的人来说,建议进行心周排水.

关键词:
肺癌是一种肺癌.恶性心周溢出 恶性心周溢出心脏周围的输液.心脏周围转移的转移.周心 - 周周窗的窗口.

更多相关视频

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.3K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

521

相关实验视频

Last Updated: Jan 13, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.4K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.3K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

521

科学领域:

  • 在瘤学瘤学.
  • 心胸外科手术 心胸外科手术
  • 抚慰性护理是一种缓解性护理.

背景情况:

  • 恶性心周溢出 (MPE) 是固体瘤的罕见但具有挑战性的并发症.
  • 管理MPE往往需要有效和安全的治疗策略.

研究的目的:

  • 评估心周-腹膜窗口 (PPW) 作为MPE的最终治疗方法的疗效和长期结果.
  • 将PPW与MPE的其他管理策略进行比较.

主要方法:

  • 在2010年至2023年期间接受PPW的44名患者的回顾性和前性分析.
  • 收集的数据包括手术,并发症,死亡率和复发率.
  • 相关的手术如视频胸腔镜和皮肤间排水也得到了注意.

主要成果:

  • 30天的死亡率为9%.
  • 对PPW的成功率,定义为没有需要进一步干预的复发,为95.5%.
  • 8名患者出现心周溢血的复发,只有2名患者需要进一步干预.

结论:

  • 周心周窗 (PPW) 是对MPE的安全有效的最终治疗方法,用于短期预后有利的患者.
  • 穿皮心周排水是对预后不太有利的患者更合适的治疗方法.